Flemming Ørnskov, CEO of Galderma, says its initial public offering in Switzerland is the “next natural step” for the dermatology company.
Galderma CEO says it’s an ‘excellent time’ for Swiss IPO
2024-03-06T09:19:28-05:00March 6th, 2024|
Related Posts
-
Games Global files to withdraw U.S. IPO plans
May 13th, 2024 -
Viking CEO: We are very different from big cruise lines
May 1st, 2024 -
Viking prices IPO at $24 per share
May 1st, 2024